New "AMEX GOURMET CLUB Avenue" Showcases Culinary Creations
from 15 Popular Restaurants
HONG KONG, Oct. 7, 2026 /PRNewswire/ -- American Express today announced its return to the Hong Kong Wine & Dine Festival as a Premium Sponsor. This year, the Company will present the all-new "AMEX GOURMET CLUB Avenue", bringing together 15 of Hong Kong's popular restaurants to showcase an enticing array of culinary creations inspired by flavors from around the world. Eligible American Express Card Members can also enjoy a range of exclusive benefits and experiences designed to enrich every moment at this annual gastronomic event.
Introducing "AMEX GOURMET CLUB Avenue"
Since its launch, AMEX GOURMET CLUB has offered Card Members in Hong Kong access to curated dining experiences and year-round exclusive privileges at a selection of established restaurants. This year, American Express extends the AMEX GOURMET CLUB dining experience to a larger stage at the Hong Kong Wine & Dine Festival with the "AMEX GOURMET CLUB Avenue". Featuring 15 popular dining partners, the Avenue will showcase an exciting variety of culinary creations, from beloved local favorites to acclaimed fine dining. Festivalgoers can savor the diversity of Hong Kong's vibrant dining scene all in one destination, while discovering the culinary experiences at the heart of AMEX GOURMET CLUB.
Participating Restaurants at the "AMEX GOURMET CLUB Avenue":
| AKATSUKI IZAKAYA | Ami | Arbor |
| Beefbar | Belon | Bo Innovation |
| Chiu Tang | CIAK | ÉPURE |
| Forum Restaurant | Jija by Vicky Lau | L'atelier de Joël Robuchon |
| Ming Court | New Punjab Club | Ryota Kappou Modern |
AKATSUKI IZAKAYA
Ami
Arbor
Beefbar
Belon
Bo Innovation
Chiu Tang
CIAK
ÉPURE
Forum Restaurant
Jija by Vicky Lau
L'atelier de Joël Robuchon
Ming Court
New Punjab Club
Ryota Kappou Modern
Exclusive Benefits for American Express Card Members at the Hong Kong Wine & Dine Festival
Eligible Card Members can enjoy a range of exclusive offers, including:
- Priority Booking: Exclusive festival ticket sale for eligible American Express Card Members will be between October 7 to 11, 2026[1], ahead of the general public sale.
- Dedicated American Express Lane: Access a dedicated lane for ticket purchases and Tasting Pass redemption for a seamless start to the festival experience.
- Grand Wine Pass Offer: Enjoy HK$50 savings on online and on-site purchases of Grand Wine Passes[2].
- Token Top-up Savings: Enjoy 20% savings on token top-ups at American Express kiosks.
- AMEX GOURMET CLUB Avenue Complimentary Food Perks: Receive a complimentary food item at designated restaurant booths at the AMEX GOURMET CLUB Avenue upon a single net transaction of HK$200 or above on any booth, ticket, or token purchase onsite using an eligible American Express Card[3].
- Jebsen Wines and Spirits Offer: Enjoy 10% savings on regular-priced wines at the Jebsen Wines and Spirits booth with an eligible American Express Card[4].
The Platinum Card Members can also visit the AMEX FAN ZONE booth (B402-403), where they can redeem a limited-edition Amex Thumb Camera upon referring a friend to apply for The Platinum Card®.
Terms and Conditions apply to all benefits and offers, which may be subject to designated booking requirements, redemption cap, spending requirements, blackout dates and other exclusions. For more details, please click here.
Please download high-resolution photos here.
| [1] Priority Booking period is from 4pm on October 7, 2026 till 11:59pm on October 11, 2026 or when all available tickets for Priority Booking are sold out, whichever comes first.
[2] Eligible Card Members can enjoy HK$50 savings on Grand Wine Tasting Pass purchased online at the designated platform from 12am on October 12, 2026 till 11:30pm on November 1, 2026, and onsite from October 29, 2026 till November 1, 2026.
[3] Eligible Card Members must present the eligible receipt to on-site American Express staff and scan the designated QR code via the Amex Experiences App onsite to complete the redemption process. Each eligible Card Member is limited to one redemption per day. Offer period is from October 29, 2026 till November 1, 2026.
[4] Under the laws of Hong Kong, intoxicating liquor must not be sold or supplied in the course of business to any person under the age of 18. American Express and the Participating Merchants reserve the right to request valid proof of identity at any time when selling, supplying or serving alcoholic beverages for the purpose of age verification. Offer period is from October 29, 2026 till November 1, 2026. |
[1] Priority Booking period is from 4pm on October 7, 2026 till 11:59pm on October 11, 2026 or when all available tickets for Priority Booking are sold out, whichever comes first.
[2] Eligible Card Members can enjoy HK$50 savings on Grand Wine Tasting Pass purchased online at the designated platform from 12am on October 12, 2026 till 11:30pm on November 1, 2026, and onsite from October 29, 2026 till November 1, 2026.
[3] Eligible Card Members must present the eligible receipt to on-site American Express staff and scan the designated QR code via the Amex Experiences App onsite to complete the redemption process. Each eligible Card Member is limited to one redemption per day. Offer period is from October 29, 2026 till November 1, 2026.
[4] Under the laws of Hong Kong, intoxicating liquor must not be sold or supplied in the course of business to any person under the age of 18. American Express and the Participating Merchants reserve the right to request valid proof of identity at any time when selling, supplying or serving alcoholic beverages for the purpose of age verification. Offer period is from October 29, 2026 till November 1, 2026.
ABOUT AMERICAN EXPRESS
American Express (NYSE: AXP) is a global payments and premium lifestyle brand powered by technology. Our colleagues around the world back our customers with differentiated products, services and experiences that enrich lives and build business success.
Founded in 1850 and headquartered in New York, American Express' brand is built on trust, security and service, and a rich history of delivering innovation and Membership value for our customers. We seek to provide the world's best customer experience every day to a broad range of consumers, small and medium-sized businesses, and large corporations, and we build and manage relationships with millions of merchants across our global network.
For more information about American Express, please visit americanexpress.com/hk、americanexpress.com/en-us/newsroom/ and ir.americanexpress.com
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
American Express Returns to Hong Kong Wine & Dine Festival with Exclusive Card Member Offers and Curated Culinary Experiences
- Participates in CPHI Milan 2026, Expanding Manufacturing AX Reach in Pharma
- Showcasing key solutions for factory design, production operations, and quality management using the theme "Autonomous Factory in Pharma"
SEOUL, South Korea and MILAN, Oct. 7, 2026 /PRNewswire/ -- LG CNS, a leading AI Transformation company in Korea, is expanding its manufacturing AX business with a showcase of pharma-specific smart factory technologies at CPHI Milan 2026, the world's largest pharmaceutical and biotech exhibition.
The Convention on Pharmaceutical Ingredients (CPHI) is a global pharma and biotech trade show held at various global venues throughout the year, including the United States, Europe, Asia, and the Middle East. The Milan show is CPHI's flagship event, drawing around 60,000 visitors and roughly 3,000 companies from more than 160 countries. It is widely regarded as the premier stage on which the latest technologies and trends of the global pharma and biotech industry converge. LG CNS is the only Korean company participating in the newly created "AI & Tech" zone this year.
The theme of LG CNS's booth is Autonomous Factory in Pharma and is designed around the introduction of three smart factory solutions connecting factory design, production operations, and quality management. Pharma and biotech companies building or expanding production facilities can adopt these solutions across the entire process, from factory construction through ongoing operations.
For the factory design stage, LG CNS presents Factova Worldworks, a digital twin-based virtual validation simulator that recreates the actual factory in a virtual space. It models the factory layout in 3D to review the optimal placement of pharmaceutical manufacturing equipment, the routes that workers will take within the planned factory, and the path along which raw materials are to be transferred. Pharmaceutical factories separate zones such as cleanrooms and production areas to prevent raw material contamination. Worker access permissions also differ by zone, so planning their routes carefully in advance is more essential than in general manufacturing factories.
Factova Control is a data standardization and equipment control solution for the production operations stage. It automatically converts process data such as raw material ID numbers and formulations into a unified format, unit, and notation so that every manufacturing step works from consistent data. This lets customers respond immediately when adding new equipment or changing process workflows. The solution also detects equipment anomalies and predicts failures, using AI to analyze electrical current, temperature, and vibration data in real time to flag early warning signs.
The quality management solution analyzes data such as production volume, raw material temperature changes, and equipment operation history to check for product quality issues. It also supports everything from root-cause investigations to follow-up actions when problems are identified. Notably, when it detects an anomaly midway through a process, it immediately calculates alternatives to resolve the issue and then applies them to the next production step, proactively preventing defective products.
An AI agent trained on quality data also drafts the Annual Product Quality Review (APQR). Pharma and biotech companies conduct annual quality reviews to comply with each country's Good Manufacturing Practice (GMP) regulations and document the results in the APQR. Previously, staff collected, analyzed, and verified the required data by hand, a process that could take months. LG CNS has automated the entire process with AI, cutting the time required by more than 90%.
"The manufacturing AX solutions we are showcasing at this exhibition are tailored to pharma so we can support our pharma and biotech customers with intelligent automation across the entire process, from factory design to quality management," said Eddie Jang, Head of the Chemical/Battery Division at LG CNS. "As a turnkey provider covering every area of manufacturing, we will continue to use our advanced solutions to address the challenges of developing pharmaceutical manufacturing sites, which demand high precision and strict quality standards, and help customers produce medicines in a more automated and efficient way."
About LG CNS
LG CNS is a leading Korean AX (AI Transformation) company that continues to pioneer various emerging technologies, including AI, robotics, cloud computing, data center, and smart engineering, encompassing smart factories and smart logistics, as well as digital marketing. The company also leads the market through innovative system integration (SI) and system management (SM) capabilities across finance, manufacturing, the public sector, and various other industries. For more information, please visit https://www.lgcns.com.
SEOUL, South Korea and MILAN, Oct. 7, 2026 /PRNewswire/ -- LG CNS, a leading AI Transformation company in Korea, is expanding its manufacturing AX business with a showcase of pharma-specific smart factory technologies at CPHI Milan 2026, the world's largest pharmaceutical and biotech exhibition.
The Convention on Pharmaceutical Ingredients (CPHI) is a global pharma and biotech trade show held at various global venues throughout the year, including the United States, Europe, Asia, and the Middle East. The Milan show is CPHI's flagship event, drawing around 60,000 visitors and roughly 3,000 companies from more than 160 countries. It is widely regarded as the premier stage on which the latest technologies and trends of the global pharma and biotech industry converge. LG CNS is the only Korean company participating in the newly created "AI & Tech" zone this year.
The theme of LG CNS's booth is Autonomous Factory in Pharma and is designed around the introduction of three smart factory solutions connecting factory design, production operations, and quality management. Pharma and biotech companies building or expanding production facilities can adopt these solutions across the entire process, from factory construction through ongoing operations.
For the factory design stage, LG CNS presents Factova Worldworks, a digital twin-based virtual validation simulator that recreates the actual factory in a virtual space. It models the factory layout in 3D to review the optimal placement of pharmaceutical manufacturing equipment, the routes that workers will take within the planned factory, and the path along which raw materials are to be transferred. Pharmaceutical factories separate zones such as cleanrooms and production areas to prevent raw material contamination. Worker access permissions also differ by zone, so planning their routes carefully in advance is more essential than in general manufacturing factories.
Factova Control is a data standardization and equipment control solution for the production operations stage. It automatically converts process data such as raw material ID numbers and formulations into a unified format, unit, and notation so that every manufacturing step works from consistent data. This lets customers respond immediately when adding new equipment or changing process workflows. The solution also detects equipment anomalies and predicts failures, using AI to analyze electrical current, temperature, and vibration data in real time to flag early warning signs.
The quality management solution analyzes data such as production volume, raw material temperature changes, and equipment operation history to check for product quality issues. It also supports everything from root-cause investigations to follow-up actions when problems are identified. Notably, when it detects an anomaly midway through a process, it immediately calculates alternatives to resolve the issue and then applies them to the next production step, proactively preventing defective products.
An AI agent trained on quality data also drafts the Annual Product Quality Review (APQR). Pharma and biotech companies conduct annual quality reviews to comply with each country's Good Manufacturing Practice (GMP) regulations and document the results in the APQR. Previously, staff collected, analyzed, and verified the required data by hand, a process that could take months. LG CNS has automated the entire process with AI, cutting the time required by more than 90%.
"The manufacturing AX solutions we are showcasing at this exhibition are tailored to pharma so we can support our pharma and biotech customers with intelligent automation across the entire process, from factory design to quality management," said Eddie Jang, Head of the Chemical/Battery Division at LG CNS. "As a turnkey provider covering every area of manufacturing, we will continue to use our advanced solutions to address the challenges of developing pharmaceutical manufacturing sites, which demand high precision and strict quality standards, and help customers produce medicines in a more automated and efficient way."
About LG CNS
LG CNS is a leading Korean AX (AI Transformation) company that continues to pioneer various emerging technologies, including AI, robotics, cloud computing, data center, and smart engineering, encompassing smart factories and smart logistics, as well as digital marketing. The company also leads the market through innovative system integration (SI) and system management (SM) capabilities across finance, manufacturing, the public sector, and various other industries. For more information, please visit https://www.lgcns.com.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
LG CNS Showcases Pharma-Specific Manufacturing AX at World's Largest Pharma-Biotech Show
